Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

CUSIP: 04746L104

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, $0.0001 Par Value
Shares outstanding
9,614,000
Total 13F shares
22,084,894
Share change
+91,779
Total reported value
$65,591,691
Put/Call ratio
13%
Price per share
$2.97
Number of holders
94
Value change
+$171,025
Number of buys
50
Number of sells
34

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
13F
Company
50%
4,797,278
$14,632,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
26%
2,484,782
$7,578,000 30 Jun 2022
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
20%
1,878,000
$5,728,000 30 Jun 2022
13F
PATHSTONE FAMILY OFFICE, LLC
13F
Company
18%
1,688,840
$5,150,963 30 Jun 2022
13F
VANGUARD GROUP INC
13F
Company
17%
1,610,580
$4,912,000 30 Jun 2022
13F
BAKER BROS. ADVISORS LP
13F
Company
11%
1,040,834
$3,175,000 30 Jun 2022
13F
STATE STREET CORP
13F
Company
9.5%
910,375
$2,777,000 30 Jun 2022
13F
CITADEL ADVISORS LLC
13F
Company
8.8%
848,987
$2,589,000 30 Jun 2022
13F
Bristlecone Advisors, LLC
13F
Company
7.3%
700,926
$2,138,000 30 Jun 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
6%
581,003
$1,772,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
6%
574,941
$1,753,000 30 Jun 2022
13F
Hudson Bay Capital Management LP
13F
Company
4.9%
475,000
$1,449,000 30 Jun 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
4.5%
428,385
$1,306,000 30 Jun 2022
13F
Nuveen Asset Management, LLC
13F
Company
1.2%
111,205
$940,000 30 Jun 2022
13F
NORTHERN TRUST CORP
13F
Company
2.9%
280,044
$855,000 30 Jun 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
2.9%
278,433
$849,000 30 Jun 2022
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
2.8%
268,131
$818,000 30 Jun 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
2.5%
238,061
$726,000 30 Jun 2022
13F
Logos Global Management LP
13F
Company
2.3%
220,000
$671,000 30 Jun 2022
13F
Jefferies Group LLC
13F
Company
2.1%
201,261
$613,846 30 Jun 2022
13F
GROUP ONE TRADING LLC
13F
Company
1.6%
153,115
$467,000 30 Jun 2022
13F
OSAIC HOLDINGS, INC.
13F
Company
1.4%
135,019
$412,000 30 Jun 2022
13F
Laird Norton Wetherby Trust Company, LLC
13F
Company
1.2%
120,000
$366,000 30 Jun 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.2%
115,900
$353,000 30 Jun 2022
13F
AWH Capital, L.P.
13F
Company
1.2%
115,000
$351,000 30 Jun 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
1.1%
105,600
$322,000 30 Jun 2022
13F
P SCHOENFELD ASSET MANAGEMENT LP
13F
Company
1%
100,000
$305,000 30 Jun 2022
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.99%
95,192
$290,000 30 Jun 2022
13F
Bank of New York Mellon Corp
13F
Company
0.98%
94,300
$287,000 30 Jun 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.92%
88,802
$271,000 30 Jun 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.7%
67,244
$205,000 30 Jun 2022
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.7%
66,900
$204,000 30 Jun 2022
13F
MORGAN STANLEY
13F
Company
0.69%
66,018
$202,000 30 Jun 2022
13F
BARCLAYS PLC
13F
Company
0.61%
58,337
$177,000 30 Jun 2022
13F
UBS Group AG
13F
Company
0.59%
56,835
$173,000 30 Jun 2022
13F
Point72 Asset Management, L.P.
13F
Company
0.57%
55,000
$168,000 30 Jun 2022
13F
IEQ CAPITAL, LLC
13F
Company
0.52%
49,922
$152,000 30 Jun 2022
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.49%
47,394
$145,000 30 Jun 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.49%
47,313
$144,000 30 Jun 2022
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.44%
42,005
$128,000 30 Jun 2022
13F
MARTINGALE ASSET MANAGEMENT L P
13F
Company
0.42%
40,107
$123,000 30 Jun 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.42%
40,076
$122,000 30 Jun 2022
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.37%
36,045
$110,000 30 Jun 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.36%
34,308
$105,000 30 Jun 2022
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.35%
33,900
$103,000 30 Jun 2022
13F
EASTERLY INVESTMENT PARTNERS LLC
13F
Company
0.35%
33,500
$102,000 30 Jun 2022
13F
Clarius Group, LLC
13F
Company
0.34%
32,825
$100,000 30 Jun 2022
13F
Squarepoint Ops LLC
13F
Company
0.33%
31,972
$98,000 30 Jun 2022
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.33%
31,800
$97,000 30 Jun 2022
13F
XTX Topco Ltd
13F
Company
0.32%
30,983
$94,000 30 Jun 2022
13F

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q3 2022

As of 30 Sep 2022, Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,084,894 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, PATHSTONE FAMILY OFFICE, LLC, BAKER BROS. ADVISORS LP, STATE STREET CORP, Bristlecone Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, and BANK OF AMERICA CORP /DE/. This page lists 94 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
89
Q3 2022 holders
94
Holder diff
5
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.